Trial
NCT01887587
Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Ehab L Atallah
Collaborators
—
Condition
Relapsed or Refractory Acute Lymphoblastic Leukemia
Intervention
MLN9708
Why stopped
SAE- risk of overall protocol treatment outweighs benefits
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-22